3,317
Views
19
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Identifying the drivers of patients’ reliance on short-acting β2-agonists in asthma

, MA, , BA & , BEng, MSc, PhD
Pages 1094-1101 | Received 27 Sep 2019, Accepted 22 Apr 2020, Published online: 29 May 2020

References

  • Oung AB, Kosirog E, Chavez B, Brunner J, Saseen JJ. Evaluation of medication adherence in chronic disease at a federally qualified health center. Ther Adv Chronic Dis. 2017;8(8-9):113–120. doi:10.1177/2040622317714966.
  • van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7(1):55. doi:10.1186/1472-6963-7-55.
  • Braido F, Baiardini I, Puggioni F, Garuti S, Pawankar R, Walter Canonica G. Rhinitis: adherence to treatment and new technologies. Curr Opin Allergy Clin Immunol. 2017;17(1):23–27. doi:10.1097/ACI.0000000000000331.
  • Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.005.
  • GINA. Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: www.ginasthma.org. 2019.
  • O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50(3):1701103. doi:10.1183/13993003.01103-2017.
  • Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. doi:10.1016/S0140-6736(17)30879-6.
  • Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the Recognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi:10.1038/npjpcrm.2014.9.
  • Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93(2):88–94. doi:10.1016/S0954-6111(99)90296-2.
  • Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6):1810–1817. doi:10.1164/ajrccm.157.6.9712007.
  • Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130(1):65S–72S. doi:10.1378/chest.130.1_suppl.65S.
  • Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?. J Pediatr Psychol. 2006;31(8):846–858. doi:10.1093/jpepsy/jsj096.
  • Chapman S, Dale P, Svedsater H, Stynes G, Vyas N, Price D, et al. Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication. NPJ Prim Care Respir Med. 2017;27(1):61.
  • Murphy KR, Meltzer EO, Blaiss MS, Nathan RA, Stoloff SW, Doherty DE. Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey. Allergy Asthma Proc. 2012;33(1):54–64. doi:10.2500/aap.2011.32.3518.
  • Maspero JF, Jardim JR, Aranda A, Tassinari C P, Gonzalez-Diaz SN, Sansores RH, Moreno-Cantu JJ, Fish JE. Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America. World Allergy Organ J. 2013;6(1):19. doi:10.1186/1939-4551-6-19.
  • Thompson PJ, Salvi S, Lin J, Cho YJ, Eng P, Abdul Manap R, Boonsawat W, Hsu J-Y, Faruqi RA, Moreno-Cantu JJ, et al. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia‐Pacific countries and Hong Kong. Respirology. 2013;18(6):957–967. doi:10.1111/resp.12137.
  • Sastre J, Fabbri LM, Price D, Wahn HU, Bousquet J, Fish JE, Murphy K, Sears MR. Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada. World Allergy Organ J. 2016;9(1):13. doi:10.1186/s40413-016-0105-4.
  • Menzies-Gow A, Chiu G. Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals' perceptions of asthma control with validated ACT scores. NPJ Prim Care Respir Med. 2017;27(1):48. doi:10.1038/s41533-017-0050-x.
  • Berelson B. Content analysis in communication research. Glencoe, IL: Free Press; 1952.
  • Miller L, Schuz B, Walters J, Walters EH. Mobile technology interventions for asthma self-management: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2017;5(5):e57. doi:10.2196/mhealth.7168.
  • Walders N, Kopel SJ, Koinis-Mitchell D, McQuaid EL. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr. 2005;146(2):177–182. doi:10.1016/j.jpeds.2004.10.014.
  • Beasley R, Bird G, Harper J, Weatherall M. The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity. Eur Respir J. 2018;52(5):1800694. doi:10.1183/13993003.00694-2018.
  • Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax. 2004;59(1):26–30. doi:10.1136/thx.2003.015297.
  • Azzi EA, Kritikos V, Peters MJ, Price DB, Srour P, Cvetkovski B, Bosnic-Anticevich S. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey. BMJ Open. 2019;9(8):e028995. doi:10.1136/bmjopen-2019-028995.
  • Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy, Asthma Immunol. 2007;98(4):322–328. doi:10.1016/S1081-1206(10)60877-0.
  • Dima AL, the ASTRO-LAB group, Hernandez G, Cunillera O, Ferrer M, de Bruin M, Group A-L. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2015;45(4):994–1018. doi:10.1183/09031936.00172114.
  • Barnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–468. doi:10.4187/respcare.03200.
  • Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;20(11):CD000011.
  • O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK, et al. Inhaled combined budesonide–formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876. doi:10.1056/NEJMoa1715274.
  • Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319(14):1485–1496. doi:10.1001/jama.2018.2769.
  • Lycett H, Wildman E, Raebel EM, Sherlock JP, Kenny T, Chan A. Treatment perceptions in patients with asthma: synthesis of factors influencing adherence. Respir Med. 2018;141:180–189. doi:10.1016/j.rmed.2018.06.032.